Episode 7 | Stem Cell Revolution | Homologous Schmologous
Description
Join us as we decode the FDA's playbook on homologous use! In this episode, we dive into the critical differences between HCT/Ps and drugs, unravel real-world examples, and explore the regulatory drama that shapes regenerative medicine. Tune in to discover how a simple definition can redefine the future of cellular therapies!Join the Conversation:Your feedback is crucial! Ask us anything in the comments about stem cell therapies and their regulation, or share your experiences.Don't forget to like, subscribe, and hit the bell icon for more updates on stem cell research and its revolutionary potential in healthcare. Check out our website in the description below for more information or to order your exclusive "Not Plastic Bag" t-shirt!
Links:
HOPE STORE: https://www.hope.bio/merch
WEBSITE - https://www.hope.bio
INSTAGRAM - https://www.instagram.com/hope.bio/
TWITTER - https://twitter.com/hopebiosciences
FACEBOOK - https://www.facebook.com/hopebiosciences
#HopeBiosciences #StemCellResearch #YearInPhotos #Inspiration#StemCellRevolution #FDA #Regulation #MinimalManipulation #StemCellTherapy #2025
United States
